Given the previously described role of LAT2 in glutamine transport and metabolism, we hypothesized that LAT2 could promote GEM chemoresistance in pancreatic cancer cells through glutamine-dependent mTOR activation. Here, MTOR is linked to familial pancreatic carcinoma.